Feb 24, 2022, “A single-nucleotide-polymorphism in the 5′-flanking region of msx1 gene as a predictive marker candidate for platinum-based therapy of esophageal carcinoma” has been published in the Therapeutic Advances in Medical Oncology.
Feb 24, 2022, “A single-nucleotide-polymorphism in the 5′-flanking region of msx1 gene as a predictive marker candidate for platinum-based therapy of esophageal carcinoma” has been published in the Therapeutic Advances in Medical Oncology.